Compare Mutual Funds
Risk
Very High
-
Rating
1.0
-
Min SIP Amount
₹500
-
Expense Ratio
2.41
-
NAV
₹15.72
-
Fund Started
18 Oct 2021
-
Fund Size
₹211.30 Cr
-
Exit Load
Exit load of 0.50%, if redeemed within 3 months.
-
1 Year
-2.44%
-
3 Year
19.19%
-
5 Year
-
-
Equity
99.18%
-
Cash
0.82%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 11.80% |
Divi's Laboratories Ltd. | 8.77% |
Apollo Hospitals Enterprise Ltd. | 6.60% |
Max Healthcare Institute Ltd. | 5.50% |
Torrent Pharmaceuticals Ltd. | 5.28% |
Aurobindo Pharma Ltd. | 4.99% |
Lupin Ltd. | 4.20% |
Laurus Labs Ltd. | 3.65% |
Alkem Laboratories Ltd. | 3.12% |
Fortis Healthcare Ltd. | 2.91% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.
-
Launch Date
18 Oct 2021
-
